Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Elderly cancer patients may benefit from geriatric support

NCT ID NCT02704832

Disease control Sponsor: Institut Bergonié Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Sep 18, 2026 · Updated 2 times

Summary

This study looked at whether a special care plan led by a geriatrician and a nurse could improve survival and quality of life for older adults (70+) with advanced cancer. 792 patients with breast, colorectal, lung, prostate, bladder, ovarian cancer, or lymphoma took part. The approach was compared to usual cancer care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

792 people

The number who actually took part.

Started

Sep 2016

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

70 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: 1. Patient older 70 years and older 2. Performance status 0 to 3 (WHO) 3. G8 and QLQ-C30 questionnaires 'score are available 4. No previous geriatric evaluation during cancer treatment 5. Locally advanced or metastatic disease : 1. 1st line medical treatment : * Breast cancer : locally advanced or metastatic disease, hormone-resistant and Her2 negative, * Colon and rectum : metastatic (unresectable metastasis), * Prostate cancer : metastatic and refractory to hormonal castration, * Bladder cancer : locally advanced or metastatic, * Ovarian cancer : advanced stage (IIb to IV), * Lung cancer : metastatic non-small cell, * Lymphomas (indolent and aggressive) 2. Or 2nd line medical treatment : * Breast cancer : locally advanced or metastatic disease, hormone-resistant and Her2 negative, * Colon and rectum : metastatic (unresectable metastasis), * Prostate cancer : metastatic and refractory to hormonal castration, * Ovarian cancer : advanced stage (IIb to IV), * Lymphomas (indolent and aggressive) 6. Life expectancy over 6 months 7. Signed informed consent 8. Patients with a French social security in compliance with the French law relating to biomedical research (Article L.1121-11 of French Public Health Code). Exclusion Criteria: 1. Patient who already received 2 medical treatment lines 2. Exclusive 1st or 2nd treatment lines of : * Hormonotherapy (except for prostate cancer : abiteratone acetate is allowed), * Surgery, * Radiotherapy, 3. "Best supportive care" treatment 4. Patient unable to understand quality of life questionnaire 5. Patient unable to follow and comply with the study procedures because of any geographical, social or psychological reasons. 6. Patient placed under guardianship 7. Planned concomitant participation to another medical interventional trial during the 12 months following the inclusion in the randomized study PREPARE 8. Previous enrolment in the present study

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Bladder cancer are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

breast cancer breast neoplasm colorectal cancer colorectal neoplasm lung cancer lung neoplasm lymphoma non-small cell lung carcinoma ovarian cancer prostate cancer urinary bladder carcinoma Urinary Bladder Neoplasms

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Bladder cancer Breast cancer Colorectal cancer Lung cancer Lymphoma Ovarian cancer Prostate cancer

Contacts and locations

Locations

  • AP-HP Henri Mondor

    Créteil, 94000, France

  • AP-HP Hôpital Saint Louis

    Paris, 75010, France

  • CHU de Bordeaux

    Bordeaux, 33600, France

  • Centre CARIO - HPCA

    Pleurin Sur Mer, 22190, France

  • Centre Catherine de Sienne

    Nantes, 44202, France

  • Centre Eugène Marquis

    Rennes, 35042, France

  • Centre Georges François Leclerc

    Dijon, 21079, France

  • Centre Hospitalier Annecy Genevois

    Pringy, 74374, France

  • Centre Hospitalier Emile Roux

    Le Puy-en-Velay, 43000, France

  • Centre Hospitalier Intercommunal de Castres Mazamet

    Castres, 81108, France

  • Centre Hospitalier Intercommunal de Cornouaille

    Quimper, 29107, France

  • Centre Hospitalier Intercommunal de Créteil

    Créteil, 94010, France

  • Centre Hospitalier Métropôle Savoie Chambéry

    Chambéry, 73011, France

  • Centre Hospitalier Privé de Saint Grégoire

    Saint-Grégoire, 35760, France

  • Centre Hospitalier René Dubos

    Pontoise, 95300, France

  • Centre Hospitalier Universitaire de Caen

    Caen, 14033, France

  • Centre Hospitalier Universitaire de Clermont-Ferrand

    Clermont-Ferrand, 63000, France

  • Centre Hospitalier Universitaire de Grenoble

    Grenoble, Auvergne-Rhône-Alpes, 38043, France

  • Centre Hospitalier Universitaire de Lille

    Lille, 59037, France

  • Centre Hospitalier Universitaire de Martinique

    Fort de France, 97261, France

  • Centre Hospitalier Universitaire de Nantes

    Saint-Herblain, 44800, France

  • Centre Hospitalier Universitaire de Nîmes

    Nîmes, 30029, France

  • Centre Hospitalier Universitaire de Poitiers

    Poitiers, 86000, France

  • Centre Hospitalier Universitaire de Rennes

    Rennes, 35033, France

  • Centre Hospitalier Universitaire de Rouen

    Rouen, 76031, France

  • Centre Hospitalier Universitaire de Strasbourg

    Strasbourg, 67091, France

  • Centre Hospitalier Universitaire de Tours

    Tours, 37170, France

  • Centre Hospitalier de Beauvais

    Beauvais, 60021, France

  • Centre Hospitalier de Chinon

    Chinon, 37500, France

  • Centre Hospitalier de Dax

    Dax, 40107, France

  • Centre Hospitalier de Mont de Marsan

    Mont-de-Marsan, 40000, France

  • Centre Hospitalier de Pau

    Pau, 64046, France

  • Centre Hospitalier de Saint-Malo

    St-Malo, 35403, France

  • Centre Hospitalier de Tourcoing

    Tourcoing, 59208, France

  • Centre Jean Godinot

    Reims, 51726, France

  • Centre Jean Perrin

    Clermont-Ferrand, 63011, France

  • Centre Léon Bérard

    Lyon, 69373, France

  • Clinique Anne d'Artois

    Béthune, 62400, France

  • Clinique Mutualiste Eugène André

    Lyon, 69003, France

  • GHPSO Senlis Creil Picardie

    Senlis, 60300, France

  • Hospices Civils de Lyon

    Pierre-Bénite, 69495, France

  • Hôpital Saint Joseph Saint Luc

    Lyon, 69007, France

  • Infirmerie Protestante de Lyon

    Caluire-et-Cuire, 69300, France

  • Institut Bergonié Centre Régional de Lutte Contre le Cancer

    Bordeaux, 33076, France

  • Institut Claudius Regaud

    Toulouse, 31059, France

  • Institut Paoli Calmettes

    Marseille, 13273, France

  • Institut de Cancérologie de Lorraine

    Nancy, 54519, France

  • Institut de Cancérologie de Montpellier

    Montpellier, 34298, France

  • Institut de Cancérologie de l'Ouest

    Angers, France

  • Polyclinique Francheville

    Périgueux, 24000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.